insights_auto
Why is ORX down 3.08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.85
arrow_downward
-3.08%(-0.027) 1D
Nov 16, 5:29:42 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56M
Avg. vol.
777.72K
Volume
415.89K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56M
Avg. vol.
777.72K
Volume
415.89K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
24 minutes ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Investor's Business Daily
·
1 hour ago
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
Investing.com
·
32 minutes ago
Why is SPDR S&P 500 ETF sliding today?
FXStreet
·
3 hours ago
The S&P 500 will find a new leader
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com